NEU 1.54% $19.80 neuren pharmaceuticals limited

Merck to acquire Prometheus in a US$ 10.8 b deal, page-63

  1. 362 Posts.
    lightbulb Created with Sketch. 1058
    Wow, this company is worth ~AUD$16B, but it doesn't have any revenue or any approved drugs on the market (yet). It's drug for ALS failed, but their Ph 3 results for Aficamten for hypertrophic cardiomyopathy were very good and seems likely the drug will be approved.

    Analyst https://seekingalpha.com/article/4591775-cytokinetics-temper-expectations-aficamten-crowded-hcm-market estimated the drug, if successful, could have peak sales of US$1.4 billion.

    They apparently have several other trials in progress related to this.

    Compares pretty favourably with Neuren in terms of stage and potential I'd have to say. Although Neuren's currently approved drug is tied up with Acadia they also arguably have greater market potential as well I'd say.

    hottod likely will have a much better commentary to offer ;-)
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
(20min delay)
Last
$19.80
Change
0.300(1.54%)
Mkt cap ! $2.528B
Open High Low Value Volume
$19.49 $19.92 $19.25 $5.352M 271.4K

Buyers (Bids)

No. Vol. Price($)
1 1000 $19.78
 

Sellers (Offers)

Price($) Vol. No.
$19.80 516 1
View Market Depth
Last trade - 16.10pm 17/06/2024 (20 minute delay) ?
Last
$19.80
  Change
0.300 ( 0.98 %)
Open High Low Volume
$19.41 $19.92 $19.25 77870
Last updated 15.59pm 17/06/2024 ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.